Shree Ganesh Remedies Ltd Share Price

Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE
₹605.75
-10.30-1.67% (1D)
As on 20 Nov 2026 at 15:58
As of 20 Nov 2026 at 15:58, Shree Ganesh Remedies Ltd is trading at ₹605.75. The 52-week range stands at ₹381.10–₹759.00, with a market cap of ₹777.70 crore. At a P/E of 64.17 and a dividend yield of 0.00%, it is a small-cap stock in the Pharmaceuticals sector.

SGRL Price Chart

Market Cap
₹777.70 Cr
PE Ratio
64.17
ROCE
9.90%

Shree Ganesh Remedies Ltd Performance

Shree Ganesh Remedies Ltd Fundamentals

Know More
Market Cap₹777.70 Cr
ROE7.31%
P/E Ratio (TTM)64.17
EPS (TTM)₹9.44
P/B Ratio4.69
Dividend Yield0.00%
Industry P/E91.72
Book Value₹129.15
Debt to Equity0.16
Face Value₹10

Shree Ganesh Remedies Ltd Shareholding Pattern

Know More
Promoter72.8%
Foreign Institutions0%
Mutual Funds0%
Domestic Institutions1%
Public26.2%

Shree Ganesh Remedies Ltd Financial Statements

Know More
No data for this view.

Shree Ganesh Remedies Ltd Peer Comparison

Know More
StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Sun Pharmaceutical Industries Ltd
₹1,885.10
-14.90(-0.78%)
4,52,298.61,583.7 - 2,046.9
Torrent Pharmaceuticals Ltd
₹4,698.80
87.80(+1.90%)
1,78,727.33,672.3 - 5,250.0
Dr Reddys Laboratories Ltd
₹1,390.50
-10.40(-0.74%)
1,16,144.51,101.0 - 1,414.9
Cipla Ltd
₹1,414.95
-3.55(-0.25%)
1,14,312.11,165.7 - 1,539.7
Lupin Ltd
₹2,010.00
11.20(+0.56%)
91,915.91,892.9 - 2,529.5

About Shree Ganesh Remedies

Shree Ganesh Remedies Limited was originally incorporated as a private company as 'Shree Ganesh Remedies Private Limited' at Ahmedabad on April 27, 1995. Subsequently the Company was converted into a Public Limited named 'Shree Ganesh Remedies Limited' on July 28, 2017. The Company has carved a niche in the industry of manufacturing pharmaceutical intermediates and fine chemicals. Shree Ganesh Remedies is a ISO 9001:2015, ISO 14001:2015 BS and OHSAS 18001:2007 certified Company and is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry. The Company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, alzheimers and anti-viral. The Products are manufactured for export market and also for domestic and foreign markets. The Company entered the International market in 2006 and are on regular basis exporting its products to various countries. The manufacturing facility is divided into three manufacturing plants namely Plant I, II and III spread across 9715 square meters having different product manufacturing capabilities and process. The manufacturing process is supported by Total Quality Management techniques and is supervised through various quality control equipment's and qualified personnel. The Products are manufactured for export market and also for domestic and foreign markets. In October 2017, the Company came up with a Public Issue of 23,76,000 Fresh Equity Shares by raising equity funds aggregating to Rs 8.56 Crores. In Unit I, Plant 5 was commissioned and made operational in 2018. In 2019, the Company started commercial production at the new production plant at GIDC, Ankleshwar. It acquired Ashok Pharma Chem (Partnership Firm) on December 24, 2019. In 2020, it launched New Advance Pharmaceutical Intermediates substituting the import intermediates. High Pressure Reaction Block was commissioned in 2023. The Company commissioned Block 8 in 2025. In FY 2026, it completed the pilot trials for CRAMS projects, commissioned a new pilot facility and advanced Block 7 towards commissioning.

Parent Organisation—
Founded1995
Managing DirectorChandubhai Kothia
NSE SymbolSGRL

Shree Ganesh Remedies Ltd Resistance and Support levels

R3624.52R2621.40R1619.48S1613.25S2611.33S3608.22605.75

Shree Ganesh Remedies Ltd Technicals

Current Price
₹605.75 ₹10.30 (-1.67%)
Bearish
12
Bullish
0
  • 20 Day4.4%
  • 50 Day4.9%
  • 100 Day5.6%
  • 200 Day5.6%

Shree Ganesh Remedies Ltd Latest News

View More
27 OCT 2026 | Tuesday
Shree Ganesh Remedies to review quarterly results at a board meeting on October 31
09 OCT 2026 | Friday
Shree Ganesh Remedies confirms compliance with SEBI regulations for the September quarter
26 SEPT 2026 | Saturday
Shree Ganesh Remedies halts securities trading ahead of financial results declaration
08 AUG 2026 | Saturday
Shree Ganesh Remedies to review quarterly results at board meeting on August 12, 2026

2026

Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced

Frequently asked questions

The share price of Shree Ganesh Remedies Ltd is ₹605.75 as of 20 Nov 2026 at 15:58.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now